D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
WST holding history
West Pharmaceutical Services Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
WST overviewAll 13F holders of WSTFull Q2 2026 holdings
- Shares (Q2 2026)
- 12,890
- Value
- $4.63M
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 12,890 | $4.63M | <0.1% | −1,111−7.9% | Reduced | Holders |
| Q1 2026 | 14,001 | $3.51M | <0.1% | +14,001 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −127,146−100.0% | Sold out | Holders |
| Q3 2025 | 127,146 | $33.4M | <0.1% | −157,190−55.3% | Reduced | Holders |
| Q2 2025 | 284,336 | $62.2M | 0.1% | +181,314+176.0% | Added | Holders |
| Q1 2025 | 103,022 | $23.1M | <0.1% | −322,893−75.8% | Reduced | Holders |
| Q4 2024 | 425,915 | $139.5M | 0.2% | +417,995+5,277.7% | Added | Holders |
| Q3 2024 | 7,920 | $2.38M | <0.1% | −7,322−48.0% | Reduced | Holders |
| Q2 2024 | 15,242 | $5.02M | <0.1% | −9,604−38.7% | Reduced | Holders |
| Q1 2024 | 24,846 | $9.83M | <0.1% | −4,198−14.5% | Reduced | Holders |
| Q4 2023 | 29,044 | $10.2M | <0.1% | +29,044 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −8,498−100.0% | Sold out | Holders |
| Q2 2023 | 8,498 | $3.25M | <0.1% | +7,370+653.4% | Added | Holders |
| Q1 2023 | 1,128 | $390.8K | <0.1% | −10,843−90.6% | Reduced | Holders |
| Q4 2022 | 11,971 | $2.82M | <0.1% | −44,155−78.7% | Reduced | Holders |
| Q3 2022 | 56,126 | $13.8M | <0.1% | −27,887−33.2% | Reduced | Holders |
| Q2 2022 | 84,013 | $25.4M | <0.1% | +82,789+6,763.8% | Added | Holders |
| Q1 2022 | 1,224 | $503.0K | <0.1% | +571+87.4% | Added | Holders |
| Q4 2021 | 653 | $306.0K | <0.1% | +653 | New | Holders |